TrialRetina (Philadelphia, Pa.)2020

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY.

Calvin Mein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.